SC-41930

N/A

Report date: 2022/03/03 17:34:05

NME

Base Information

Drug NameSC-41930

Drug Alias NameSC-41930CGS 24115

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLeukotriene B4 receptor antagonists

TargetsLeukotriene B4 receptor

Therapy Area/IndicationsPsoriasisInflammatory Bowel DiseasesRheumatic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsPsoriasisInflammatory Bowel DiseasesRheumatic Diseases

ATC CodeN/A